Aurinia Pharmaceuticals (AUPH) had the highest return in 2013 by a mid-cap US stock, returning 5,088.9%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Aurinia Pharmaceuticals (AUPH) | 2013 | 5,088.91% |
Almonty Industries Inc Common Shares (ALM) | 2013 | 849.8% |
Globalstar, Inc Common Stock (GSAT) | 2013 | 446.88% |
ACADIA Pharmaceuticals (ACAD) | 2013 | 422.8% |
Nexstar Broadcasting (NXST) | 2013 | 419.94% |
Arrowhead Pharmaceuticals (ARWR) | 2013 | 402.31% |
BioCryst Pharmaceuticals (BCRX) | 2013 | 377.99% |
Vipshop (VIPS) | 2013 | 365.13% |
Catalyst Pharmaceuticals (CPRX) | 2013 | 348.28% |
Aehr Test Systems (AEHR) | 2013 | 255.17% |
Celldex Therapeutics (CLDX) | 2013 | 251.38% |
ArcBest (ARCB) | 2013 | 248.7% |
JOYY (JOYY) | 2013 | 246.76% |
Plug Power (PLUG) | 2013 | 210% |
MGIC Investment (MTG) | 2013 | 205.8% |
Ambarella (AMBA) | 2013 | 182.89% |
Axos Financial (AX) | 2013 | 177.92% |
Camtek (CAMT) | 2013 | 173.64% |
Astronics (ATRO) | 2013 | 169.23% |
HCI (HCI) | 2013 | 156.1% |
Vicor (VICR) | 2013 | 147.6% |
Ligand Pharmaceuticals (LGND) | 2013 | 147.18% |
Icahn Enterprises (IEP) | 2013 | 142.86% |
Vera Therapeutics (VERA) | 2013 | 140.82% |
VNET Group Inc DRC (VNET) | 2013 | 135.44% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
